Then you complete a short pre-screen questionnaire to provide basic health information
FDA Clears First Oral GLP-1 for Weight Loss
Casanova F, Santos L (2016) Encapsulation of cosmetic active ingredients for topical applicationa review
Glycemic, inflammatory and oxidative stress responses to different high-intensity training protocols in type 1 diabetes: A randomized clinical trial
KPV (Lysine-Proline-Valine) Primary uses: Inflammatory conditions Gut inflammation (Crohn's, colitis) Skin inflammation Immune modulation Typical dosing: Injectable: 500-1,000mcg daily Duration: 4-12 weeks Administration: Subcutaneous injection Also available as oral and nasal spray Special notes: Powerful anti-inflammatory Minimal side effects Useful for autoimmune conditions Less commonly used than BPC-157/TB-500 GHK-Cu (Copper Peptide) Primary uses: Wound healing Skin regeneration Hair growth Anti-inflammatory effects Tissue repair Typical dosing: Injectable: 1-2mg, 3-5 times per week Intranasal: 2-3mg daily (alternative to injection) Duration: Ongoing for anti-aging benefits Administration: Subcutaneous injection Intranasal spray (alternative delivery) Special notes: Strong evidence for tissue regeneration Also used topically for skin (different from injectable) Well-tolerated with minimal side effects See our copper peptides guide for complete information
Digestive Support for GLP-1 Treatments: GLP-1 agonists frequently cause digestive side effects, with nausea occurring in 40% of cases, vomiting in 25%, and bowel disturbances in 23%, often leading to treatment discontinuation (Sun F et al., Diabetes Technology & Therapeutics , 2015)
